John R Fischer

Cypress Ridge launches Cresso Health to provide back-office services to insurance agencies

Launched in 2022, Cypress Ridge targets payor services, healthcare providers, health IT and pharmaceutical services companies with enterprise values between $20m and $100m.

Avista unveils Trillium acquisition, rebrands as Avista Healthcare Partners

'As competition in the private equity space intensifies, rebranding helps Avista stand out as a specialist in healthcare,' managing director Amanda Heravi told PE Hub.

PE firms scan radiology market for investments: 7 recent deals

Apax, Duke Street and NMS Capital are among several PE firms investing in radiology practices and imaging equipment manufacturers.

Rare disease pharma incentives enticing PE: 7 recent deals

SK Capital, Nordic Capital Partners and KKR are among the many PE firms looking at specialty pharma companies developing rare disease treatments.

Physician practices still appeal to PE: Troutman Pepper‘s Mateusz Saykiewicz

'Despite the slowdown in PE-backed healthcare services transactions in 2023, in part due to the regulatory environment, there is still value to be unlocked.'

Hamilton Lane expected to announce investment in Avista-backed Cosette

Avista will retain a significant equity stake and jointly manage Cosette’s growth alongside Hamilton Lane, PE Hub has learned.

Why Vista has closed five take-private deals in less than two years

Michael Fosnaugh discusses the Model N deal and Vista's strategy.

Growing appeal for online pharma: 5 deals announced in 2024

BPOC, Archimed and OMERS are among the PE firms buying and selling companies that sell over-the-counter pharmacy items online.

Health Catalyst Capital Management debuts Quarvis Health via portfolio company merger

HCC invested in Sibley in January 2020 and merged it with Health4Home through a preferred stock offering to create Quarvis Health.

Sentinel Capital scores Carrier's industrial fire business for $1.425bn

The sale was announced the same day as Carrier's sale of Kidde-Fenwal Inc., which has declared bankruptcy, to Pacific Avenue Capital Partners.